http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#Head http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#assertion http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#provenance http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#pubInfo http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#assertion http://purl.obolibrary.org/obo/DOID_1574 http://www.w3.org/1999/02/22-rdf-syntax-ns#type https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1574 http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/DRUGBANK:DB00904 http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association http://www.w3.org/2000/01/rdf-schema#label While alcohol induces an increase of dopamine, ondansetron reduces the release of the neurotransmitter by blocking the 5-HT3 receptors. Several studies investigated the effectiveness of ondansetron by dividing alcoholic individuals into two subgroups based on their genotype for the promoter region of the SLC6A4 gene coding for the serotonin transporter (5-HTTLPR L/S polymorphism). The study showed that the patients with the LL genotype treated with ondansetron responded better in terms of alcohol amount and days of abstinence, compared to the other subgroups. Based on these results, researchers have further investigated genotype LL carriers, by analyzing the role of a functional polymorphism of the SLC6A4 gene (rs1042173 [T/G] SNP). The result was that individuals who carry both 5-HTTLPR LL polymorphism and rs1042173 TT polymorphism, treated with ondansetron at the dosage of 0.5 mg/die, present a more effective response to the drug. Unfortunately, the sample of this exploratory study was too small to be validated. http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#context http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/29912214 http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#context http://www.w3.org/1999/02/22-rdf-syntax-ns#type https://w3id.org/biolink/vocab/Cohort http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#context http://www.w3.org/2000/01/rdf-schema#label adults https://identifiers.org/DRUGBANK:DB00904 http://www.w3.org/1999/02/22-rdf-syntax-ns#type https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#provenance http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-08-26T09:18:24.960707 http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#pubInfo http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#sig http://purl.org/nanopub/x/hasSignature HKO/6/WbH6tUaC0vBhS/q+EAWDcX+6Z11YP0zdctz1Vbb7g1MLWld46IbtKKqoEuI30DM9aK5UNbjEHrEkYaXal8+yk+OGuQi/5bAy/7i3ceSzsUT5sre6FuZJa/6KYJxDwW/tdYjcds8+F3hFttF+4/5FINgd33yqo4wLhfyrw= http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 http://www.w3.org/ns/prov#generatedAtTime 2021-08-26T09:18:24.960707 http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RA59XSqRVPk2FrSKMfCxyHV_NVcPGekpLer0BEIbmIb74 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY